NSTK · 01.2026Independent supplement reference
NutriStack
Edition 1.0Updated August 1, 2026

Supplement × Prescription·Evidence index

Atorvastatin and Coenzyme Q10: what the published research says

PubMed indexes 8 records that name Atorvastatin and Coenzyme Q10 together, either in the title or in an interaction, co-administration, or pharmacokinetic context. Each one is listed below with its study design and, where the abstract states one, the authors’ own conclusion, quoted and linked. This page reports that literature. It does not tell you whether to combine them.

Read this first

An evidence index, not guidance.

Every statement below is attributed to a named, dated, linked source.

This page lists published research relevant to Atorvastatin and Coenzyme Q10. It deliberately does not state whether the combination is safe, whether it interacts, in which direction, at what dose, or how far apart to take them.

The research

8 studies naming Atorvastatin and Coenzyme Q10.

Strongest relevance first: papers naming both substances in the title, then human trials and systematic reviews.

L-Carnitine, but not coenzyme Q10, enhances the anti-osteoporotic effect of atorvastatin in ovariectomized rats.

Journal of Zhejiang University. Science. B · 2016 · PMID 26739525

Comparative StudyAnimal study

“Co-administration of L-carnitine, but not coenzyme Q10, enhances the anti-osteoporotic effect of atorvastatin while antagonizing myopathy in ovariectomized rats. This could be valuable in treatment of osteoporotic patients. However, further confirmatory studies are needed.”

Murad · Authors' conclusion

Names both Atorvastatin and Coenzyme Q10 in its title.

No effect of combined coenzyme Q10 and selenium supplementation on atorvastatin-induced myopathy.

Scandinavian cardiovascular journal : SCJ · 2013 · PMID 23301875

Comparative StudyRandomized Controlled Trial

“Despite substantial increases in the serum Q10 and selenium levels following the oral supplementation, this study revealed no significant effects on SIM compared with the placebo.”

Bogsrud et al. · Authors' conclusion

Names both Atorvastatin and Coenzyme Q10 in its title.

Atorvastatin-induced changes in plasma coenzyme q10 and brain natriuretic peptide in patients with coronary artery disease.

International heart journal · 2008 · PMID 18753726

Comparative StudyHuman subjects29 participants

“In conclusion, long-term treatment with ATO might increase plasma levels of BNP in patients with CAD when it is accompanied by a greater reduction in plasma CoQ10. However, ATO-induced decreases in CoQ10 might not increase oxidative stress.”

Suzuki et al. · From the abstract

Names both Atorvastatin and Coenzyme Q10 in its title.

Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: a randomized double-blind study.

Atherosclerosis · 2007 · PMID 17681347

Randomized Controlled Trial

“These changes in plasma CoQ10 levels showed no relation to the changes in serum AST, ALT and CK levels. Further studies are needed, however, for the evaluation of CoQ10 supplementation in statin therapy.”

Mabuchi et al. · From the abstract

Names both Atorvastatin and Coenzyme Q10 in its title.

Reduction of serum ubiquinol-10 and ubiquinone-10 levels by atorvastatin in hypercholesterolemic patients.

Journal of atherosclerosis and thrombosis · 2005 · PMID 15942122

Clinical TrialComparative Study

“Percent reductions of ubiquinol-10 and those of total cholesterol showed a positive correlation (r = 0.627, p = 0.0165). As atorvastatin reduces serum ubiquinol-10 as well as serum cholesterol levels in all patients, it is imperative that physicians are forewarned about the risks associated with ubiquinol-10 depletion.”

Mabuchi et al. · From the abstract

Names both Atorvastatin and Coenzyme Q10 in its title.

The effect of pravastatin and atorvastatin on coenzyme Q10.

American heart journal · 2001 · PMID 11479481

Clinical TrialRandomized Controlled Trial

“P and A did not decrease CoQ10 despite a significant decrease in LDL levels. These findings suggest that HMG-CoA reductase inhibitors do not significantly decrease the synthesis of circulating CoQ10 in healthy subjects. Routine supplementation of CoQ10 may not be necessary when HMG-CoA reductase inhibitor therapy is administered.”

Bleske et al. · Authors' conclusion

Names both Atorvastatin and Coenzyme Q10 in its title.

The Influence of Atorvastatin, Amlodipine and Ethoxidol on Ubiquinol and Ubiquinone Endogenous Plasma Concentrations in Patients with Chronic Heart Failure.

Current drug metabolism · 2023 · PMID 37711113

Human subjects

“Amlodipine is able to neutralize the negative effect of atorvastin on the redox balance of CoQ10 in patients with CHF. An additional prescription of the antioxidant ethoxidol to standard therapy for patients with CHF was substantiated. Determination of the redox state of CoQ10 in plasma can be used to diagnose and assess the degree of oxidative stress in patients with cardiovascular diseases, as well as to assess the efficacy and safety of ongoing pharmacotherapy.”

Zozina et al. · Authors' conclusion

Names both Atorvastatin and Coenzyme Q10 in its title.

Evaluation of coenzyme Q10 combined with or without N-acetyl cysteine or atorvastatin for preventing contrast-induced kidney injury in diabetic rats.

Naunyn-Schmiedeberg's archives of pharmacology · 2021 · PMID 33630121

Animal study

“The combined use of CoQ10/atorvastatin could be a potential strategy to prevent CIN. However, future studies are warranted to test different combinations for longer prophylactic periods.”

Alshogran et al. · From the abstract

Names both Atorvastatin and Coenzyme Q10 in its title.

Limitations

What this evidence cannot tell you.

Search-based evidence indexes have real limits, and it is worth being explicit about them:

NutriStack

Track what you actually take.

NutriStack is a free iPhone app for organising a supplement routine: what you take, when, and what the published record says about it. Its exploratory interaction checker covers Atorvastatin, Coenzyme Q10, and several hundred other substances.

The checker is a research and organisation tool, not a clinical decision aid, and its per-pair assessments are excluded from search until they pass claim-level review.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.